ZA858416B - A therapeutically useful compound - Google Patents

A therapeutically useful compound

Info

Publication number
ZA858416B
ZA858416B ZA858416A ZA858416A ZA858416B ZA 858416 B ZA858416 B ZA 858416B ZA 858416 A ZA858416 A ZA 858416A ZA 858416 A ZA858416 A ZA 858416A ZA 858416 B ZA858416 B ZA 858416B
Authority
ZA
South Africa
Prior art keywords
therapeutically useful
useful compound
imidazole
benzyl
dimethyl
Prior art date
Application number
ZA858416A
Other languages
English (en)
Inventor
Raimo Einari Virtanen
Arto Johannes Karjalainen
Kauko Oiva Antero Kurkela
Antti Tapani Vaehae-Vahe
Outi Maritta Vainio-Kivinen
Original Assignee
Farmos Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmos Oy filed Critical Farmos Oy
Publication of ZA858416B publication Critical patent/ZA858416B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Stringed Musical Instruments (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA858416A 1984-12-04 1985-11-01 A therapeutically useful compound ZA858416B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI844786A FI844786A0 (fi) 1984-12-04 1984-12-04 Terapeutiskt utnyttjbar foerening.

Publications (1)

Publication Number Publication Date
ZA858416B true ZA858416B (en) 1986-07-30

Family

ID=8520010

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA858416A ZA858416B (en) 1984-12-04 1985-11-01 A therapeutically useful compound

Country Status (11)

Country Link
US (1) US4670455A (Direct)
EP (1) EP0187471B1 (Direct)
JP (1) JPS61134314A (Direct)
AT (1) ATE65694T1 (Direct)
AU (1) AU572364B2 (Direct)
DE (1) DE3583670D1 (Direct)
DK (1) DK163960C (Direct)
FI (1) FI844786A0 (Direct)
IE (1) IE58269B1 (Direct)
NZ (1) NZ213604A (Direct)
ZA (1) ZA858416B (Direct)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI864570A0 (fi) * 1986-11-11 1986-11-11 Farmos Oy Terapeutiskt anvaendbar foerening.
GB2206880B (en) 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
US5344840A (en) * 1988-02-29 1994-09-06 Orion-Yhtyma Oy 4-substituted imidazole derivatives useful in perioperative care
GB2215206B (en) 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
AR015744A1 (es) * 1998-04-01 2001-05-16 Orion Corp Uso de dexmedetomidina para sedacion en terapia intensiva
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
EP2370136A4 (en) * 2008-12-01 2015-12-30 Map Pharmaceuticals Inc INHALATIVE RELEASE PROCEDURES AND DEVICES
US8555875B2 (en) * 2008-12-23 2013-10-15 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
US20130096170A1 (en) 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
WO2013069025A1 (en) 2011-11-11 2013-05-16 Neon Laboratories Ltd. "process for the preparation of dexmedetomidine"
US8242158B1 (en) 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
US10772871B2 (en) 2013-10-07 2020-09-15 Teikoku Pharma Usa, Inc. Dexmedetomidine transdermal delivery devices and methods for using the same
TWI629067B (zh) 2013-10-07 2018-07-11 美商帝國製藥美國股份有限公司 用於經皮輸送非鎮靜量右美托咪啶之方法及組成物
KR101831290B1 (ko) 2013-10-07 2018-02-22 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 조성물을 사용하여 주의력 결핍 과잉행동 장애, 불안 및 불면증을 치료하기 위한 방법 및 조성물
US9717796B1 (en) 2016-04-20 2017-08-01 Slypharma, Llc Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container
US11839604B2 (en) 2016-12-31 2023-12-12 Bioxcel Therapeutics, Inc. Use of sublingual dexmedetomidine for the treatment of agitation
IL279713B2 (en) 2018-06-27 2025-01-01 Bioxcel Therapeutics Inc Dexmedetomidine-containing layer compositions and methods for their production
US11160791B2 (en) 2018-11-01 2021-11-02 Medefil, Inc. Dexmedetomidine injection premix formulation in ready to use (RTU) bags
WO2021016112A2 (en) 2019-07-19 2021-01-28 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2092569B (en) * 1981-02-05 1984-09-19 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB2096987B (en) * 1981-04-22 1984-04-04 Farmos Oy Substituted imidazole and imidazole derivatives and their preparation and use
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
DK368483A (da) * 1982-08-14 1984-02-15 Wellcome Found Imidazolderivater eller salte deraf, fremgangsmaade til deres fremstilling samt deres anvendelse

Also Published As

Publication number Publication date
DK508985D0 (da) 1985-11-05
AU572364B2 (en) 1988-05-05
JPS61134314A (ja) 1986-06-21
DK163960C (da) 1992-09-21
AU4997185A (en) 1986-06-12
DK163960B (da) 1992-04-27
EP0187471A3 (en) 1988-09-14
IE853024L (en) 1986-06-04
US4670455A (en) 1987-06-02
FI844786A0 (fi) 1984-12-04
EP0187471A2 (en) 1986-07-16
DK508985A (da) 1986-06-05
DE3583670D1 (de) 1991-09-05
EP0187471B1 (en) 1991-07-31
IE58269B1 (en) 1993-08-25
NZ213604A (en) 1988-09-29
ATE65694T1 (de) 1991-08-15
JPH0465050B2 (Direct) 1992-10-16

Similar Documents

Publication Publication Date Title
ZA858416B (en) A therapeutically useful compound
NO854639L (no) Formgitte hydrogelgjenstander.
AU6631986A (en) 2-((3,5-dihalo-4-aminobenzyl)) imidazolines
IT1184224B (it) Pressa oscillante
AU574965B2 (en) Cross talk, echo compensation
IT1183491B (it) Procedimento per la fabbricazione di una unita' a piastre di intercettazioone, per un cassetto di intercettazione
AU6878787A (en) Substituted 5-(1,4-piperazinyl)-2,4-diaminopyridine
AU4973785A (en) N,n1 - disubstituted imidazoles useful as hypoglycemic agents
DE3874610D1 (Direct)
AU6414286A (en) 1,2,5-substituted imidazole compounds
AU549146B2 (en) 1-(1,3-benzodioxol-5-yl)-2-pyrrolidinone
DK376882A (da) Fungicidt virksomme 1-(trihalogenmethylsulfenyl)-4-aryl-1,2,4-triazolidin-5-oner
ES8400401A1 (es) "un procedimiento para preparar un 1,4-dialcohilo inferior-3-alcoxicarbonilo inferior-pirrol-2-acetato de alcohilo inferior".
SU1269296A1 (ru) Гербицидный состав
SU1262908A1 (ru) Гидрохлорид 1-(2'-этоксиэтил)-4-фенил-4-пропионилоксипиперидина, обладающий анальгетической активностью
ES2116399T3 (es) Derivados tiazolicos de alcoxiacrilatos con una actividad fungicida.
PH23287A (en) An azole compounds, pharmaceutical composition and its use as an antimycotic
SU1124558A1 (ru) 1-фенил-5- (2′- оксифенил)-3-стирил-1,2,4-триазолы, обладающие транквилизирующим действием
SU1121940A1 (ru) Этиловый эфир [3-метил-5- 2′ -оксифенил)-1,2,4-триазолил-1] уксусной кислоты, обладающий психостимулирующим действием
JO975B1 (en) Imidisole, the method of its preparation and the active medicinal ingredients contained in it.
SU1112747A1 (ru) 2-диаллиламино-6-фенил-1,3-оксазин-4-он, проявляющий анальгетическую активность
SU1269688A1 (ru) Источник ионов
NL190929C (nl) 1-(Difenylmethyl)-4-(1,3-dioxolan-2-yl)-4-fenylbutylpiperazine, werkwijze voor de bereiding ervan alsmede farmaceutisch preparaat.
CS1029284A1 (en) Antineoplasticky ucinne estery kyselin 5-(2-amino-4-oxo-6-alkyl-3,4-dihydropyrimidin-5-yl)pentanovych
IT8420771V0 (it) Apparecchiatura per l'avanzamento automatico dei pezzi da lavorare, in particolare per l'alimentazione di presse.